A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 31
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : FIB-4
Long Form : fibrosis index based on the 4 factors
No. Year Title Co-occurring Abbreviation
2020 A longitudinal assessment of non-invasive biomarkers to diagnose and predict cystic fibrosis-associated liver disease. APRI, AUROC, CFLD, CFPD, GGT, GPR
2020 Accuracy of FibroScan in analysis of liver fibrosis in patients with concomitant chronic Hepatitis B and nonalcoholic fatty liver disease. APRI, AUROC, CHB, GPR, NAFLD, NFS
2020 Comparison and evaluation of non-invasive models in predicting liver inflammation and fibrosis of chronic hepatitis B virus-infected patients with high hepatitis B virus DNA and normal or mildly elevated alanine transaminase levels. APRI, AUROCs, GP, GPR, ROC, RPR, ULN
2020 Does regression in treatment-induced liver fibrosis reflect noninvasive tests? Assessing treatment results of hepatitis B patients who took potent antiviral drugs for 5 years. API, APRI, AST, MPV, PLT
2020 Hepatitis C infection at a tertiary hospital in South Africa: Clinical presentation, non-invasive assessment of liver fibrosis, and response to therapy. APRI, AUC, EVR, NPV, PPV, SD, SVR
2020 Red cell distribution width-to-lymphocyte ratio: A novel predictor for HBV-related liver cirrhosis. APRI, CHB, HBV-LC, LMR, NLR, PLT, RDW, RLR
2019 Fibrosis Index Based on 4 Factors (FIB-4) Predicts Liver Cirrhosis and Hepatocellular Carcinoma in Chronic Hepatitis C Virus (HCV) Patients. AAR, APRI, GPR, HCC, HCV
2019 Performance of common imaging techniques vs serum biomarkers in assessing fibrosis in patients with chronic hepatitis B: A systematic review and meta-analysis. APRI, ARFI, AUSROC, HBV, MRE
2019 Real-world effectiveness and safety of glecaprevir/pibrentasvir in Asian patients with chronic hepatitis C. AEs, CHC, GLE/PIB, HCV, SVR12
10  2019 Real-world safety and efficacy of paritaprevir/ritonavir/ombitasvir plus dasabuvir  ribavirin in patients with hepatitis C virus genotype 1 and advanced hepatic fibrosis or compensated cirrhosis: a multicenter pooled analysis. ARFI, CI, HCV-1, PrOD
11  2018 Comparative evaluation of GPR versus APRI and FIB-4 in predicting different levels of liver fibrosis of chronic hepatitis B. APRI, AUROCs, CHB, GPR, ROC
12  2018 Current noninvasive liver reserve models do not predict histological fibrosis severity in hepatocellular carcinoma. CDS, HCC
13  2018 Declining diagnostic accuracy of non-invasive fibrosis tests is associated with elevated alanine aminotransferase in chronic hepatitis B. AST, AUROCs, CHB, GGT, PLT, PLT
14  2018 Evaluation of elastography combined with serological indexes for hepatic fibrosis in patients with chronic hepatitis B. APRI, AST, CHB, CIV, HA, ROC, SWV
15  2018 Increased red cell width distribution to lymphocyte ratio is a predictor of histologic severity in primary biliary cholangitis. APRI, AUROC, PBC, RDW, RLR, RPR
16  2018 Platelet count to spleen thickness ratio is related to histologic severity of primary biliary cholangitis. APRI, AUROC, MPV, PBC, PC/ST, RPR
17  2018 Potential Role of Microfibrillar-Associated Protein 4, Fibrotic Indices and Oxidative Stress in Hepatocellular Carcinoma. APRI, CoQ10, HCC, HCV, MFAP4
18  2018 Red blood cell distribution width to platelet ratio levels in assessment of histologic severity in patients with primary biliary cholangitis. AAR, APRI, PBC, RPR
19  2018 Serum S100 calcium binding protein A4 improves the diagnostic accuracy of transient elastography for assessing liver fibrosis in hepatitis B. APRI, AUC, CHB, LSM, ROC
20  2017 Comparison of serological assessments in the diagnosis of liver fibrosis in bile duct ligation mice. AAR, APRI
21  2017 Evaluation of eLIFT for Non-invasive Assessment of Liver fibrosis and Cirrhosis in Patients with Chronic Hepatitis B Virus Infection. APRI, CHB, eLIFT
22  2017 Gamma-Glutamyl Transpeptidase-to-Platelet Ratio Predicts Significant Liver Fibrosis of Chronic Hepatitis B Patients in China. APRI, AUROC
23  2017 Prognostic role of noninvasive liver reserve markers in patients with hepatocellular carcinoma undergoing transarterial chemoembolization. ALBI, CDI, CTP, GUCI, HCC, MELD, TACE
24  2016 Diagnostic Estimation of Noninvasive Tests for Hepatic Fibrosis in Chronic Hepatitis B Patients Without a Gold Standard. APRI, CHB, GP, LSM
25  2016 Effect of Entecavir and Tenofovir Treatment on Noninvasive Fibrosis Scores: Which One Is Better? AAR, APRI, RPR
26  2016 Features of Severe Liver Disease With Portal Hypertension inPatients With Cystic Fibrosis. APRI, CF
27  2016 Red Blood Cell Distribution Width to Platelet Ratio is Related to Histologic Severity of Primary Biliary Cirrhosis. AMA-M2, APRI, AST, AUROC, PBC, RDW, RPR
28  2016 [Non-invasive fibrosis indexes in predicting acute liver function deterioration after transcatheter arterial chemoembolization]. AST, AUC, NPV, PLT, PPV, ROC
29  2015 Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection? APRI, CHB, IL-33, sST2
30  2015 FibroScan, aspartate aminotransferase and alanine aminotransferase ratio (AAR), aspartate aminotransferase to platelet ratio index (APRI), fibrosis index based on the 4 factor (FIB-4), and their combinations in the assessment of liver fibrosis in patients with hepatitis B. AAR, APRI, CHB, LS, ROC
31  2015 [Clinical study on FibroTouch and multi-parameter model for diagnosis of hepatic fibrosis in patients with chronic liver disease]. APRI, AST, LSM, ROC, TBIL